Is TMAT or JNJ a better dividend investment in 2026?

TMAT currently yields 0.02% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between TMAT and JNJ?

TMAT has a forward dividend yield of 0.02% ($0.01/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3.34 percentage points.

Home › Compare › TMAT vs JNJ

TMAT vs JNJ: Dividend Comparison 2026

TMAT yields 0.02% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 JNJ wins by $318.00 in total portfolio value· pulled ahead in Year 7

INVESTMENT

TIME HORIZON10 years

TMAT

● Live price

0.02%

Share price

$23.19

Annual div

$0.01

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$19.7K

Annual income

$2.38

Full TMAT calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — TMAT vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TMAT	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TMAT + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TMAT pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TMAT

Annual income on $10K today (after 15% tax)

$2.02/yr

After 10yr DRIP, annual income (after tax)

$2.02/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $701.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TMAT + JNJ for your $10,000?

TMAT: 50%JNJ: 50%

100% JNJ50/50100% TMAT

Portfolio after 10yr

$19.9K

Annual income

$415.08/yr

Blended yield

2.09%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TMAT

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TMAT buys

JNJ buys

No recent congressional trades found for TMAT or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTMATJNJ

Forward yield	0.02%	3.36% ✓
Annual dividend / share	$0.01	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$19.7K	$20.0K ✓
Annual income after 10y	$2.38	$827.78 ✓
Total dividends collected	$24.00 ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: TMAT vs JNJ ($10,000, DRIP)

Year	TMAT Portfolio	TMAT Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1	$10,702	$2.37	$10,676	$355.77	+$26.00 → TMAT
2	$11,454	$2.37	$11,407	$389.39	+$47.00 → TMAT
3	$12,258	$2.37	$12,198	$426.53	+$60.00 → TMAT
4	$13,118	$2.37	$13,056	$467.62	+$62.00 → TMAT
5	$14,039	$2.37	$13,987	$513.12	+$52.00 → TMAT
6	$15,024	$2.37	$14,998	$563.56	+$26.00 → TMAT
7← crossover	$16,078	$2.37	$16,098	$619.52	$20.00 → JNJ
8	$17,206	$2.37	$17,295	$681.69	$89.00 → JNJ
9	$18,413	$2.38	$18,599	$750.82	$186.00 → JNJ
10	$19,704	$2.38	$20,022	$827.78	$318.00 → JNJ

TMAT vs JNJ: Complete Analysis 2026

TMAT — Stock

The adviser seeks to achieve its objective through dynamic thematic rotation. The Adviser focuses its research primarily on identifying emerging, disruptive, and innovative themes that have a large market demand or "addressable market". The Adviser rotates among themes with large addressable markets which may range from nascent technologies to those on the cusp of widespread adoption and buys securities of ETFs investing in those themes.

Full TMAT Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this TMAT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TMAT vs SCHD TMAT vs JEPI TMAT vs O TMAT vs KO TMAT vs MAIN TMAT vs ABBV TMAT vs MRK TMAT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.